🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multi-center, open-label, phase II randomized controlled trial is to e...
Status
Suspended
Location
Sun Yat-sen Memorial Hospital
Start Date
2016-09
Trial ID
NCT02897050
This 3 arm study will assess the tolerability, safety and efficacy of 3 neo...
Status
Completed
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT00976989
Treatments Being Tested
Previous studies in Western country show that triple-negative breast cancer...
Status
Completed
Location
Multiple Locations
Start Date
2011-01-01
Trial ID
NCT01216111
Treatments Being Tested
The trial will determine the value of adding bevacizumab to chemotherapy pl...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2008-04
Trial ID
NCT00625898
Treatments Being Tested
This is an adjuvant, open, prospective, randomized study to compare: A. In...
Status
Active Not Recruiting
Location
MUG - Med. Univ.-Klinik Graz
Start Date
2007-02
Trial ID
NCT00798070
Recent clinical studies showed that triple-negative breast cancer patients ...
Status
Unknown
Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Start Date
2012-06
Trial ID
NCT01642771
Treatments Being Tested
Genomics assays that measure specific gene expression patterns in a patient...
Status
Completed
Location
University of South Alabama, Mitchell Cancer Institute
Start Date
2011-10
Trial ID
NCT01501487
Treatments Being Tested
Neoadjuvant chemotherapy (NAC) has become the standard therapy for both loc...
Status
Unknown
Location
Multiple Locations
Start Date
2017-11-27
Trial ID
NCT03349177
Treatments Being Tested